AAAAAA

   
Results: 1-9 |
Results: 9
Telithromycin: An oral ketolide for respiratory infections
Authors: Bearden, DT Neuhauser, MM Garey, KW
Citation: Dt. Bearden et al., Telithromycin: An oral ketolide for respiratory infections, PHARMACOTHE, 21(10), 2001, pp. 1204-1222
Postantibiotic effects of ABT-773 and amoxicillin-clavulanate against Streptococcus pneumoniae and Haemophilus influenzae
Authors: Neuhauser, MM Prause, JL Danziger, LH Pendland, SL
Citation: Mm. Neuhauser et al., Postantibiotic effects of ABT-773 and amoxicillin-clavulanate against Streptococcus pneumoniae and Haemophilus influenzae, ANTIM AG CH, 45(12), 2001, pp. 3613-3615
Pharmacokinetics and pharmacodynamics of ceftizoxime in patients with dosages adjusted for renal function
Authors: Neuhauser, MM McKinnon, PS Hershberger, E Rybak, MJ
Citation: Mm. Neuhauser et al., Pharmacokinetics and pharmacodynamics of ceftizoxime in patients with dosages adjusted for renal function, PHARMACOTHE, 20(5), 2000, pp. 554-561
Quinupristin-dalfopristin: An overview
Authors: Delgado, G Neuhauser, MM Bearden, DT Danziger, LH
Citation: G. Delgado et al., Quinupristin-dalfopristin: An overview, PHARMACOTHE, 20(12), 2000, pp. 1469-1485
In vitro activities of a new ketolide, ABT-773, alone and in combination with amoxicillin, metronidazole, or tetracycline against Helicobacter pylori
Authors: Pendland, SL Prause, JL Neuhauser, MM Boyea, N Hackleman, JM Danziger, LH
Citation: Sl. Pendland et al., In vitro activities of a new ketolide, ABT-773, alone and in combination with amoxicillin, metronidazole, or tetracycline against Helicobacter pylori, ANTIM AG CH, 44(9), 2000, pp. 2518-2520
Beta-lactam antibiotics
Authors: Neuhauser, MM Danziger, LH
Citation: Mm. Neuhauser et Lh. Danziger, Beta-lactam antibiotics, INFEC DIS S, 2000, pp. 151-184
Efficacy and cost of ampicillin-sulbactam and ticarcillin-clavulanate in the treatment of hospitalized patients with bacterial infections
Authors: McKinnon, PS Neuhauser, MM
Citation: Ps. Mckinnon et Mm. Neuhauser, Efficacy and cost of ampicillin-sulbactam and ticarcillin-clavulanate in the treatment of hospitalized patients with bacterial infections, PHARMACOTHE, 19(6), 1999, pp. 724-733
Outcome assessment of minimizing vancomycin monitoring and dosing adjustments (vol 19, pg 257, 1999)
Authors: Karam, CM McKinnon, PS Neuhauser, MM Rybak, MJ
Citation: Cm. Karam et al., Outcome assessment of minimizing vancomycin monitoring and dosing adjustments (vol 19, pg 257, 1999), PHARMACOTHE, 19(5), 1999, pp. 674-674
Outcome assessment of minimizing vancomycin monitoring and dosing adjustments
Authors: Karam, CM McKinnon, PS Neuhauser, MM Rybak, MJ
Citation: Cm. Karam et al., Outcome assessment of minimizing vancomycin monitoring and dosing adjustments, PHARMACOTHE, 19(3), 1999, pp. 257-266
Risultati: 1-9 |